These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34136904)

  • 1. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.
    Kennedy JJ; Whiteaker JR; Kennedy LC; Bosch DE; Lerch ML; Schoenherr RM; Zhao L; Lin C; Chowdhury S; Kilgore MR; Allison KH; Wang P; Hoofnagle AN; Baird GS; Paulovich AG
    Clin Chem; 2021 Jul; 67(7):1008-1018. PubMed ID: 34136904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy.
    Do M; Kim H; Yeo I; Lee J; Park IA; Ryu HS; Kim Y
    Clin Chem; 2020 Oct; 66(10):1339-1348. PubMed ID: 33001186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision of multiple reaction monitoring mass spectrometry analysis of formalin-fixed, paraffin-embedded tissue.
    Sprung RW; Martinez MA; Carpenter KL; Ham AJ; Washington MK; Arteaga CL; Sanders ME; Liebler DC
    J Proteome Res; 2012 Jun; 11(6):3498-505. PubMed ID: 22530795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.
    Steiner C; Tille JC; Lamerz J; Kux van Geijtenbeek S; McKee TA; Venturi M; Rubbia-Brandt L; Hochstrasser D; Cutler P; Lescuyer P; Ducret A
    Mol Cell Proteomics; 2015 Oct; 14(10):2786-99. PubMed ID: 26149442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
    Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
    Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Quantification of Proteins in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissue Using Multiplexed Mass Spectrometry Assays.
    Steiner C; Lescuyer P; Cutler P; Tille JC; Ducret A
    Mol Cell Proteomics; 2022 Nov; 21(11):100416. PubMed ID: 36152753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Protocol for Quantitative Multiple Reaction Monitoring-Based Proteomic Analysis of Formalin-Fixed, Paraffin-Embedded Tissues.
    Kennedy JJ; Whiteaker JR; Schoenherr RM; Yan P; Allison K; Shipley M; Lerch M; Hoofnagle AN; Baird GS; Paulovich AG
    J Proteome Res; 2016 Aug; 15(8):2717-28. PubMed ID: 27462933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
    Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
    Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2 copy number determination in breast cancer using the highly sensitive droplet digital PCR method.
    Alinger-Scharinger B; Kronberger C; Hutarew G; Hitzl W; Reitsamer R; Frederike KF; Hager M; Fischer T; Sotlar K; Jaksch-Bogensperger H
    Virchows Arch; 2024 Jul; 485(1):53-62. PubMed ID: 37996704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative real-time polymerase chain reaction is an alternative method for the detection of HER-2 amplification in formalin-fixed paraffin-embedded breast cancer samples.
    Pu T; Guo P; Qiu Y; Chen S; Yang L; Sun L; Ye F; Bu H
    Int J Clin Exp Pathol; 2015; 8(9):10565-74. PubMed ID: 26617766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
    Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
    BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of selected reaction monitoring for multiplex quantification of clinically validated biomarkers in formalin-fixed, paraffin-embedded tumor tissue.
    Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Hewitt SM; Bender RA; Krizman DB; Burrows J
    J Mol Diagn; 2013 Jul; 15(4):454-65. PubMed ID: 23672976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
    Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
    J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.
    Sprung RW; Brock JW; Tanksley JP; Li M; Washington MK; Slebos RJ; Liebler DC
    Mol Cell Proteomics; 2009 Aug; 8(8):1988-98. PubMed ID: 19467989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Usefulness of a One-Tube Nested Reverse Transcription Quantitative Polymerase Chain Reaction Assay for Evaluating Human Epidermal Growth Factor Receptor 2 mRNA Overexpression in Formalin-Fixed and Paraffin-Embedded Breast Cancer Tissue Samples.
    Wang HY; Ahn S; Park S; Kim S; Lee H
    Pathobiology; 2017; 84(2):57-70. PubMed ID: 27544315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
    El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
    Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipeptide Immunocapture with In-Sample Calibration Curve Strategy for Sensitive and Robust LC-MS/MS Bioanalysis of Clinical Protein Biomarkers in Formalin-Fixed Paraffin-Embedded Tumor Tissues.
    Zheng N; Taylor K; Gu H; Santockyte R; Wang XT; McCarty J; Adelakun O; Zhang YJ; Pillutla R; Zeng J
    Anal Chem; 2020 Nov; 92(21):14713-14722. PubMed ID: 33047598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
    Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
    BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples.
    Fu C; Marczyk M; Samuels M; Trevarton AJ; Qu J; Lau R; Du L; Pappas T; Sinn BV; Gould RE; Pusztai L; Hatzis C; Symmans WF
    BMC Cancer; 2021 Feb; 21(1):114. PubMed ID: 33541297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.